|
|
41 - 60 of 601 <<previous | next>>
| Drug Surveillance System Needs To Be Fixed |
The current drug surveillance system needs to be fixed, argues an editorial in this week's BMJ. The call follows a recent analysis of the diabetes drug rosiglitazone (Avandia) which raised serious questions about the drug's safety. Rosiglitazone was approved by the US Food and Drug Administration (FDA) in 1999 and by the European Medicines Agency (EMEA) in 2000.
2007-06-15 03:00 |
| ChemGenex Announces Publication Confirming Activity Of Ceflatonin In T315I-Positive CML |
ChemGenex Pharmaceuticals Limited (ASX:CXS and NASDAQ:CXSP) has announced the publication of a report in the prestigious Nature publication Leukemia confirming the positive clinical activity of the company's lead compound, Ceflatonin® against Gleevec®-resistant, chronic myeloid leukemia (CML) associated with the T315I Bcr-Abl mutation.
2007-06-14 16:00 |
| Federal Employee Program Contracts Awarded To Medco, CVS Caremark |
Pharmacy benefits managers Medco Health Solutions and CVS Caremark on Wednesday announced that each had won part of a three-year government contract to provide prescription drug benefits to federal employees, retirees and dependents enrolled in the
2007-06-12 16:00 |
| European Medicines Agency's Management Board Elects New Chair And Vice-chair |
The European Medicines Agency's Management Board elected Pat O'Mahony, Chief Executive of the Irish Medicines Board, as new chair and Lisette Tiddens-Engwirda, Secretary-General of the Standing Committee of European Doctors (CPME), as vice-chair of the Board, with three-year mandates from 7 June 2007. Accepting his election, Pat O'Mahony said, "It is my ambition to do the very best during my mandate to make a difference for public and animal health in Europe.
2007-06-12 03:00 |
| Markup Date Delayed For Generic Biotechnology Drug Bill |
The June 13 markup date for a Senate bill that would allow FDA to approve generic versions of biotechnology drugs has been pushed back a week, according to a spokesperson for Senate Health, Education, Labor and Pensions Committee Chair Edward Kennedy (D-Mass.), CongressDaily reports (Edney, CongressDaily, 6/7). The bill (
2007-06-10 10:00 |
| Drug Company Funding Of Drug Trials Greatly Influences Outcome |
In head-to-head trials of two drugs, the one deemed better appears to depend largely on who is funding the study, according to an analysis of nearly 200 statin-drug comparisons carried out between 1999 and 2005.UCSF researchers examined 192 published results of trials comparing one cholesterol-lowering statin drug to another, or to a non-statin drug.Their findings found that two links stood out.
2007-06-10 06:00 |
| Major New Study On Food Supplements In Europe Launched |
At its 43rd Annual Meeting in Warsaw from 4 - 6 June 2007 the Association of the European Self-Medication Industry (AESGP) launched a major new study on the "Regulatory Framework for Food Supplements in Europe" covering the 27 European Union Member States and Iceland, Norway, Switzerland and Croatia. The study describes the legal requirements, regulatory practices and national particularities in the countries covered.
2007-06-07 03:00 |
| Manchester Researcher Wins Libyan Award |
Abdul Gbaj, who is researching the pharmaceutical aspects of genetic and tumour sciences at the University's School of Pharmacy and Pharmaceutical Sciences, received his award from the Libyan Minister of Higher Education, Dr Akeel Hussain Akeel."When he told me I had won this award, I was very proud. There are 5,000 Libyan Masters and PhD students across the globe, 1,600 of them in the UK," Abdul said."I was very lucky to come to Manchester.
2007-06-05 22:00 |
41 - 60 of 601 <<previous | next>>
|
|
|
